Cns Pharmaceuticals Inc (CNSP) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access CNSP Annual Balance Sheets →
Tracking balance sheet results across Cns Pharmaceuticals Inc to Jun 30 2025 helps illustrate how Jun 30 2026's financial position has responded to changing business conditions.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent19.99
Cash & Short-term Investments19.00
Deferred Offering Costs DE0.07
Prepaid Expense And Other Assets Current1.87
Total Current Assets21.92
Equipment/Property/Plant Net0.02
Prepaid Expense, Noncurrent, Total PR0.00
Other Assets, Noncurrent0.00
Total Assets21.94
Liabilities
Accounts Payable and Accrued Liabilities, Current LI3.74
Notes Payable, Current NO0.00
Other Liabilities, Current0.00
Total Current Liabilities3.74
Long-term debt0.30
Total Long-term Debt0.30
Total Liabilities3.74
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock126.00
Retained Earnings / Accumulated Deficit-107.80
Other Equity0.00
Common Stockholder's Equity18.20
Total Stockholder's Equity18.20
Liabilities & Stockholder's Equity21.94
4 historic quarters locked

Sign in to unlock the full Cns Pharmaceuticals Inc balance sheet history.

About Cns Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001683168-26-006224

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.